Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Risk-MaPP: Managing the Risk of Cross Contamination

Risk-Based Manufacture of Pharmaceutical Products Risk-MaPP enables manufacturers to justify scientifically that the risk of cross contamination is under control and below acceptable limits in multi-product facilities.

Stephanie Wilkins, PharmaConsult US (December 2010)

Keywords: Risk-MaPP: Managing the Risk of Cross Contamination; Stephanie Wilkins, PharmaConsult US; Risk-Based Manufacture of Pharmaceutical Products Risk-MaPP enables manufacturers to justify scientifically that the risk of cross contamination is under control and below acceptable limits in multi-product facilities.

    View full article    |    Back to Manufacturing section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |